Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)
NCT01488578
·
clinicaltrials.gov ↗
COMPLETED
Status
11157
Enrollment
INDUSTRY
Sponsor class
Conditions
Overactive Bladder
Interventions
DRUG:
Tolterodine tartrate
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.